Human polymorphisms as clinical predictors in leprosy
- PMID: 22220182
- PMCID: PMC3246779
- DOI: 10.1155/2011/923943
Human polymorphisms as clinical predictors in leprosy
Abstract
Genetic and serum markers in human host can predict leprosy susceptibility per se as well as be useful in classification and/or prediction of clinical variants and immunological responses in leprosy. Adequate and timely assessment of potential risks associated with these 38 host leprosy genes could diminish epidemiological burden and improve life quality of patients with this still prevalent mycobacterial disease.
References
-
- Orlova M, Di Pietrantonio T, Schurr E. Review: genetics of infectious diseases: hidden etiologies and common pathways. Clinical Chemistry and Laboratory Medicine. 2011;49(9):1427–1437. - PubMed
-
- Prado Montes de Oca E, Velarde-Felix JS, Ríos-Tostado JJ, Picos-Cardenas VJ, Figuera LE. SNP 668C (-44) alters a NF-κB1 putative binding site in non-coding strand of human β-defensin 1 (DEFB1) and is associated with lepromatous leprosy. Infection, Genetics and Evolution. 2009;9(4):617–625. - PubMed
-
- Scollard DM. Leprosy research declines, but most of the basic questions remain unanswered. International Journal of Leprosy and Other Mycobacterial Diseases. 2005;73:25–27. - PubMed
-
- Montoya D, Modlin RL. Learning from leprosy: insight into the human innate immune response. Advances in Immunology. 2010;105:1–24. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
